Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: eFFECTOR Therapeutics Q3 Net Income USD -8.303 Million

Nov 13 (Reuters) - eFFECTOR Therapeutics Q3 operating income USD -7.855
million.
* Q3 operating expenses USD 7.855 million
* Q3 basic EPS USD -0.13
* Q3 EPS USD -0.13

Recent news on Effector Therapeutics

See all news